Model
Edge
4D Molecular Therapeutics
0001877012
Filing type
3
Filing date
Dec 18, 2025
Updated
Dec 19, 2025 ยท 2:12 PM
Copy reference
Filing
3
Initial Statement of Beneficial Ownership